Nothing Special   »   [go: up one dir, main page]

BE901980A - Nouveaux derives de la cyclosporine, leur preparation et leur utilisation comme medicaments. - Google Patents

Nouveaux derives de la cyclosporine, leur preparation et leur utilisation comme medicaments.

Info

Publication number
BE901980A
BE901980A BE1/011217A BE1011217A BE901980A BE 901980 A BE901980 A BE 901980A BE 1/011217 A BE1/011217 A BE 1/011217A BE 1011217 A BE1011217 A BE 1011217A BE 901980 A BE901980 A BE 901980A
Authority
BE
Belgium
Prior art keywords
medicaments
preparation
cyclosporin derivatives
novel cyclosporin
novel
Prior art date
Application number
BE1/011217A
Other languages
English (en)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848407618A external-priority patent/GB8407618D0/en
Priority claimed from GB848411922A external-priority patent/GB8411922D0/en
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE901980A publication Critical patent/BE901980A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Des cyclosporines de formule générale (I) dans lesquelles le reste de l'amino-acide en position 8 est le reste d'un (D)-acyloxy-alpha-amino-acide. Ces composés peuvent etre utilisés comme médicaments, en particulier comme immunosuppresseurs et comme agents anti-inflammatoires ou agents anti-parasitaires.
BE1/011217A 1984-03-23 1985-03-21 Nouveaux derives de la cyclosporine, leur preparation et leur utilisation comme medicaments. BE901980A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848407618A GB8407618D0 (en) 1984-03-23 1984-03-23 Organic compounds
GB848411922A GB8411922D0 (en) 1984-05-10 1984-05-10 Organic compounds

Publications (1)

Publication Number Publication Date
BE901980A true BE901980A (fr) 1985-09-23

Family

ID=26287502

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/011217A BE901980A (fr) 1984-03-23 1985-03-21 Nouveaux derives de la cyclosporine, leur preparation et leur utilisation comme medicaments.

Country Status (24)

Country Link
US (1) US4639434A (fr)
JP (1) JPH08838B2 (fr)
AT (1) AT388737B (fr)
BE (1) BE901980A (fr)
CA (1) CA1247546A (fr)
CH (1) CH667274A5 (fr)
CS (1) CS249542B2 (fr)
DE (1) DE3509809A1 (fr)
DK (1) DK128285A (fr)
ES (1) ES8702926A1 (fr)
FI (1) FI851120L (fr)
FR (1) FR2561651B1 (fr)
GB (1) GB2155936B (fr)
GR (1) GR850716B (fr)
HU (1) HU200786B (fr)
IL (1) IL74681A (fr)
IT (1) IT1199962B (fr)
LU (1) LU85819A1 (fr)
NL (1) NL8500828A (fr)
NO (1) NO851160L (fr)
NZ (1) NZ211526A (fr)
PH (2) PH23357A (fr)
PT (1) PT80149B (fr)
SE (1) SE461334B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0314862A1 (fr) 1984-10-04 1989-05-10 Sandoz Ag Conjugués immunogènes comprenant des cyclosporines
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
ES2059558T3 (es) * 1987-06-17 1994-11-16 Sandoz Ag Ciclosporins y su uso como productos farmaceuticos.
EP0373260B1 (fr) * 1987-06-22 1994-03-09 Merck & Co. Inc. Dérivés de cyclosporine avec un acide aminé modifié en position 8
US5227467A (en) * 1987-08-03 1993-07-13 Merck & Co., Inc. Immunosuppressive fluorinated cyclosporin analogs
ATE109970T1 (de) * 1987-09-03 1994-09-15 Univ Georgia Res Found Cyclosporin-augenmittel.
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
US5089390A (en) * 1987-09-04 1992-02-18 Syntex (U.S.A.) Inc. 2-methyl-4-hexene- and 2-methyl-4-heptene-1,2-diol derivatives
US5236899A (en) * 1987-11-16 1993-08-17 Merck & Co., Inc. 6-position cyclosporin a analogs as modifiers of cytotoxic drug resistance
US4914188A (en) * 1987-11-16 1990-04-03 Merck & Co., Inc. Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
CH679119A5 (fr) * 1988-05-13 1991-12-31 Sandoz Ag
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US5122511A (en) * 1990-02-27 1992-06-16 Merck & Co., Inc. Immunosuppressive cyclosporin analogs with modified amino acids at position-8
US5202310A (en) * 1990-06-06 1993-04-13 Levy Gary A Cyclosporine metabolites
ATE148469T1 (de) * 1990-11-02 1997-02-15 Sandoz Ag Zyklosporine
EP0674178B1 (fr) 1990-11-20 2002-08-28 Dade Behring Marburg GmbH Essai immunologique de cyclosporine
US5747330A (en) * 1996-06-05 1998-05-05 Poli Industria Chimica Antibiotic producing microbe
NZ502362A (en) 1997-10-08 2001-05-25 Isotechnika Inc Deuterated cyclosporine A derivatives and their use as immunomodulating agents
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
US5990274A (en) 1997-11-25 1999-11-23 Dade Behring Inc. Cyclosporine derivatives and uses thereof
US7449544B2 (en) * 1999-11-30 2008-11-11 Cyclacel Limited p21 peptides
RU2321593C9 (ru) * 2001-10-19 2008-06-20 Изотехника Инк. Синтез аналогов циклоспорина
EP1435910B9 (fr) * 2001-10-19 2010-02-03 Isotechnika Inc. Nouveaux preconcentres en microemulsion d'analogues de cyclosporine
JP2006524232A (ja) * 2003-03-17 2006-10-26 アルバニー モレキュラー リサーチ インコーポレーティッド 新規サイクロスポリン
JP2008514702A (ja) * 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド 新規シクロスポリン類似体およびそれらの薬学的使用
WO2006039163A2 (fr) * 2004-09-29 2006-04-13 Amr Technology, Inc. Analogues d'alcyne de cyclosporine et utilisations pharmaceutiques de ceux-ci
JP2008515886A (ja) * 2004-10-06 2008-05-15 エーエムアール テクノロジー インコーポレイテッド シクロスポリンアルキンおよびそれらの医用薬剤としての有用性
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
WO2008069917A2 (fr) 2006-11-20 2008-06-12 Scynexis, Inc. Nouveaux peptides cycliques
KR20190002731A (ko) 2010-12-15 2019-01-08 콘트라빌 파마슈티컬스, 인코퍼레이티드 아미노산 1 및 3에서 변형된 사이클로스포린 유사체 분자
AU2012229236B2 (en) 2011-03-11 2017-05-18 Beth Israel Deaconess Medical Center, Inc. Anti-CD40 antibodies and uses thereof
CN104877013B (zh) * 2015-06-03 2018-04-20 兰州大学 环孢菌素t及其制备方法和应用
CA3002789A1 (fr) 2015-09-04 2017-03-09 Primatope Therapeutics Inc. Anticorps humanises anti-cd40 et leurs utilisations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4384996A (en) * 1981-01-09 1983-05-24 Sandoz Ltd. Novel cyclosporins
JPS57140753A (en) * 1981-01-09 1982-08-31 Sandoz Ag Novel cyclosporine

Also Published As

Publication number Publication date
NO851160L (no) 1985-09-24
ES541465A0 (es) 1987-01-16
SE8501392L (sv) 1985-09-24
IT1199962B (it) 1989-01-05
IT8547852A1 (it) 1986-09-22
SE461334B (sv) 1990-02-05
HU200786B (en) 1990-08-28
PT80149B (en) 1987-03-23
PT80149A (en) 1985-04-01
HUT38370A (en) 1986-05-28
GB2155936A (en) 1985-10-02
PH21868A (en) 1988-03-25
CH667274A5 (de) 1988-09-30
LU85819A1 (fr) 1985-12-12
JPH08838B2 (ja) 1996-01-10
IL74681A0 (en) 1985-06-30
ATA86385A (de) 1989-01-15
CA1247546A (fr) 1988-12-28
DK128285A (da) 1985-09-24
FR2561651A1 (fr) 1985-09-27
AT388737B (de) 1989-08-25
FI851120L (fi) 1985-09-24
PH23357A (en) 1989-07-14
NZ211526A (en) 1988-08-30
IL74681A (en) 1989-09-10
FR2561651B1 (fr) 1990-03-09
CS249542B2 (en) 1987-03-12
FI851120A0 (fi) 1985-03-20
DK128285D0 (da) 1985-03-21
US4639434A (en) 1987-01-27
DE3509809A1 (de) 1986-01-09
SE8501392D0 (sv) 1985-03-21
GB2155936B (en) 1987-09-16
GB8507270D0 (en) 1985-04-24
GR850716B (fr) 1985-07-19
NL8500828A (nl) 1985-10-16
ES8702926A1 (es) 1987-01-16
JPS60215700A (ja) 1985-10-29
IT8547852A0 (it) 1985-03-22

Similar Documents

Publication Publication Date Title
BE901980A (fr) Nouveaux derives de la cyclosporine, leur preparation et leur utilisation comme medicaments.
AU588860B2 (en) Improvements in or relating to organic compounds
FR2432503A1 (fr) Nouveaux nonapeptides, leur procede de preparation et leur application comme medicaments
BE905954A (fr) Preparation pulverisable de dihydropyridine, son procede de production et son utilisation pharmaceutique.
FR2607493B1 (fr) Nouveaux composes pharmacologiquement actifs, leurs procedes de preparation et les compositions en contenant
HUP9900338A2 (hu) Sokfunkciós enzim
IT8520769A0 (it) Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono.
CA2331870A1 (fr) Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BE899073A (fr) Nouveaux composes azoliques, leur preparation et leur utilisation comme antifongiques et fongicides
BE904368A (fr) Nouveaux derives de pyridylmethoxy- et methylmercaptoanilines, utiles notamment comme antiasthmatiques, leur fabrication et medicaments les contenant.
BE905109A (fr) Derives de distamycine et leur procede de fabrication.
BE904796A (fr) Nouveaux derives du morphinane et de la morphine, leur preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant.
BE1002213A5 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments.
FR2391191A1 (fr) Nouveaux composes polypeptidiques, lyeptidiques, leur preparation et leur application comme medicaments
BE905790A (fr) Peptide de venin de serpent arretant la croissance.
EP0272174A3 (fr) Préparations d'adenyl cyclase purifiées, procédé d'obtention de ces préparations et leurs applications biologiques
IE872239L (en) Pyridopyrimidinediones and quinazolines
FR2622446B1 (fr) Agent pour reduire la nephrotoxicite produite par l'administration de cyclosporine
CA2330351A1 (fr) Nouvelles urees lineaires ou cycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MA20926A1 (fr) Composes heterocycliques azotes nouveaux, compositions les contenant, leur preparation et leur application pour reduire la perte d'humidite de plantes et pour accroitre le rendement de cultures.
FR2692899B1 (fr) Nouveaux dérivés peptidiques actifs dans les processus d'adhésion cellulaire, leur procédé de préparation et les compositions pharmaceutiques qui les renferment.
BE1003219A3 (fr) NOUVEAUX DERIVES DE L'OCTAHYDROBENZO[g]QUINOLEINE, LEUR PREPARATION ET LEUR UTILISATION COMME MEDICAMENTS.
FR2593501B1 (fr) Nouveaux derives bis (r-oxyimino)-5,7 dihydro-6,7 (5h) dibenzo (a,c) cycloheptene, leurs procedes de preparation et leur application comme medicaments
FR2423220A2 (fr) Nouveaux acylanilides et compositions pharmaceutiques en contenant
NO176177C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-amino-tetrahydroisokinolinderivater

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: NOVARTIS A.G.

Effective date: 19990331